Xero Limited (ASX:XRO)

Verve Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	28,900	23,690	20,226	13,428	15,303	18,526
Market Cap Growth	17.13%	17.13%	50.62%	-12.25%	-17.40%	92.96%
Enterprise Value	27,999	22,994	20,171	13,531	15,283	18,458
Last Close Price	174.75	154.75	133.32	89.42	102.75	126.53
PE Ratio	130.82	114.44	126.22	-	-	1020.15
Forward PE	90.56	77.83	96.99	130.29	-	266.44
PS Ratio	15.13	12.40	12.86	10.27	15.07	23.77
PB Ratio	14.48	11.87	15.83	13.64	15.99	27.04
P/TBV Ratio	31.29	25.65	53.92	158.19	221.63	77.02
P/FCF Ratio	39.83	32.65	37.67	37.47	76.04	97.20
P/OCF Ratio	39.18	32.12	37.25	36.82	69.92	92.26
EV/Sales Ratio	14.65	12.03	12.83	10.35	15.05	23.68
EV/EBITDA Ratio	78.05	67.26	80.73	137.04	333.41	258.98
EV/EBIT Ratio	84.97	69.78	84.97	157.48	463.87	305.98
EV/FCF Ratio	38.59	31.69	37.57	37.75	75.94	96.84
Debt / Equity Ratio	0.61	0.61	0.88	1.09	0.99	1.27
Debt / EBITDA Ratio	3.39	3.39	4.18	9.14	15.38	10.26
Debt / FCF Ratio	1.68	1.68	2.09	2.98	4.70	4.58
Asset Turnover	0.57	0.57	0.63	0.58	0.50	0.53
Quick Ratio	1.18	1.18	1.15	4.65	5.08	6.79
Current Ratio	1.24	1.24	1.22	4.95	5.45	7.13
Return on Equity (ROE)	12.70%	12.70%	14.27%	-10.88%	-1.02%	3.38%
Return on Assets (ROA)	6.11%	6.11%	5.94%	2.38%	1.02%	2.58%
Return on Capital (ROIC)	7.37%	7.37%	6.72%	2.70%	1.19%	3.14%
Return on Capital Employed (ROCE)	15.20%	15.20%	17.10%	4.10%	1.70%	3.50%
Earnings Yield	0.72%	0.87%	0.79%	-0.79%	-0.06%	0.10%
FCF Yield	2.51%	3.06%	2.66%	2.67%	1.31%	1.03%
Buyback Yield / Dilution	-1.12%	-1.12%	-1.93%	-1.11%	1.01%	-4.72%

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.